Zhou Q, Ou Y, Dai X, Chen X, et al. Prevalence of tumour-infiltrating CD103(+) cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome. Br J Cancer 2023 Feb 9. doi: 10.1038/s41416-023-02183.
PMID: 36759726